GOSS.OQ - Gossamer Bio Inc
Gossamer Bio Inc
H.C. Wainwright & Co., LLC

Two-Study NDA Package: A Credible Regulatory Path Could Emerge in Mid-June FDA meeting; 4Q25 Results; Reiterate Buy

公司
GOSS.OQ
日期
2026-03-19
分析师
Patrick R. Trucchio, CFA
页数
8
需要登录
请登录后购买研报或生成音频内容。
Two-Study NDA Package: A Credible Regulatory Path Could Emerge in Mid-June FDA meeting; 4Q25 Results; Reiterate Buy - Gossamer Bio Inc (GOSS.OQ) | 研报说 MoneyTalk | 研报说